Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Eslicarbazepine Acetate in Refractory Partial Seizures
NCT00957372Phase 3Completed
- Sponsor
- BIAL
- Start
- Dec 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eslicarbazepine acetate in partial epilepsy, sponsored by BIAL. Started Dec 2004; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00957372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957372.